V. Riambau, MD, PhD. Professor and Chief of Vascular Surgery Division CardioVascular Institute, Hospital Clinic, University of Barcelona

Similar documents
Mid-term results of the global ANCHOR registry regarding the treatment of type I endoleaks

V. Riambau and G. Mestres Vascular Surgery Division. Cardiovascular Institute Hospital Clinic. University of Barcelona

Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,

You struggle to get into the fenestration: try a steerable guiding

NEW PERSPECTIVES ON CHALLENGING AAA NECKS. And why graft design matters in treating Reverse Taper Necks. Supplement to. Sponsored by Endologix, Inc.

Conformability without Compromise

LINC James F. McKinsey, M.D.

Conformability without Compromise. Now FDA APPROVED

Conformability without Compromise

Valiant Navion device enhancements: a case-based approach to Navion s clinical value

Zenith Alpha System, Designed for Easy and Durable repairs. Prof. Elixène JEAN-BAPTISTE (Nice)

DEC DEPARTMENT OF HEALTH & HUMAN SERVICES

PER F ORM ANC E b y d e s i g n. Pioneering TEVAR Therapy, Time and Time Again. CONFORMABLE

EVALUATING PROXIMAL AND DISTAL FIXATION ABILITY OF 8 ENDOGRAFTS USED IN EVAR

A New Endoprosthesis With Sensing Capability

The hypogastric issue: how important is the hypogastric patency? Why not a sandwich technique? Nilo J Mosquera, MD.

V. Riambau, MD, PhD Prof and Chief of Vascular Surgery Division Cardiovascular Institute, Hospital Clínic of Barcelona

Aortica: Taking Aim at Complex EVAR with a Novel Endograft Fenestration Technology

Lombard Medical, Inc. (NASDAQ:EVAR) June 2016

ENDOVASCULAR TREATMENT OF COMPLEX ABDOMINAL AND THORACOABDOMINAL

Wireless Implantable Micromachined Pressure Sensors: Approach and Clinical Demonstration

Branched Grafts for Thoracoabdominal Aneurysms: Off-Label Use of FDA-Approved Devices

From the Society for Clinical Vascular Surgery

Protect the Neck. Lieven Maene, MD. Marc Bosiers Koen Deloose Joren Callaert. Patrick Peeters Jürgen Verbist. Lieven Maene Roel Beelen.

1. Until the CE Mark suspension has been lifted, the AFX product should not be implanted in patients.

Modular branched endograft system for aortic aneurysm repair: evaluation in a human cadaver circulation model

Predictive and patient-specific numerical simulations of endovascular surgery for aortic abdominal aneurysms. Michel Rochette

Effect of improved endograft design on outcome of endovascular aneurysm repair

Aortic Endografts Market

This 2013 TEVAR update represents a follow-up to the 2012 VDM article that summarized the

Edito PORTRAIT I N F O R M I A N A L Y S E I I M P R O V E. Nathalie Couvreur

Do More with Less Dose Optimised Imaging Protocols for Endovascular Procedures

Results with intraoperative 3-D angiography

How we deal with aortic endograft infection. Elena Iborra, Emma Espinar, Ramon Vila Hospital Universitari de Bellvitge Barcelona, Spain

The Next Generation of Stents for the Lower Extremity: What s on the Horizon?

Bioresorbable Stent Implantation for Tibial Disease

PEAC. May 13 // May Marie Lannelongue Hospital le Plessis-Robinson, FRANCE. Paris Endovascular Aortic Course

TOBA II and TOBA III Clinical Programme Updates

New Fully Absorbable Patch Based Large Hole Vascular Closure Device Arne Schwindt, MD

Fenestrated and branched endografts: assessment of proximal aortic neck fixation

A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION. Vascular Implant Surveillance & Interventional Outcomes Network

The phase I multicenter trial (STAPLE-1) of the Aptus Endovascular Repair System: Results at 6 months and 1 year

Detection of endograft fractures with multidetector row computed tomography

Simulator Features. Imaging. Device Simulation. Patient Management. Educational Features

Cre8 TM BTK polymer-free DES technology: the Activ8 clinical trial

Perspective on initial Limflow experience in the US. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

Unique technologies for the endoluminal treatment of complex PAD lesions

Endovascular Device Testing A Survey of Requirements for Product Validation

Coronary Stent Innovation: EPC Capture

Patient-specific simulation of stent-graft deployment within an abdominal aortic aneurysm

Fenestrated and Branched Endografts: Assessment of Proximal Aortic Neck Fixation

Advancing minimally invasive. therapeutics through novel device. development. Minima y Invasive New Technologies T H E L E O N A M. A N D H A R R Y B.

European Journal of Vascular and Endovascular Surgery

REBOA. Todd E. Rasmussen, MD

The evolution of stent design for chronic iliac vein obstruction

Failure modes of thoracic endografts: Prevention and management

Thoracoscopic Pneumonectomy. 10 th Annual Masters in Minimally Invasive Thoracic Surgery

EndoVascular hybrid Trauma and bleeding Management (EVTM)

University Hospital. Parkland Hospital

Comparative Effectiveness and the United States Healthcare System: Success, Failure and Politics

Pre-op Planning. Dedicated to planning of Endovascular Interventions

Tissue Engineered Vascular Grafts

Enrollment Challenges in Cardiothoracic Surgical Clinical Trials

EndoVascular hybrid Trauma and bleeding Management (EVTM)

Company Update. 28 May REVA Medical, Inc.

Dr. Alexandre Abizaid Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil

ACCESS OPTIONS FOR PATIENTS WITH VENOUS OUTFLOW INSUFFICIENCY SYSTEM MERIT IS COMMITTED TO DIALYSIS ACCESS

Clinical Trials and Medical Device Innovation in the US New Policies and Trends

Status of branched endovascular aortic arch repair

The Importance of Vessel Preparation

Atherectomy as Primary Therapy for Lower Extremity Artery Disease: What will Be its Role in the Drug-Eluting Era

KEY TO INNOVATION AT VASCUTEK JAPAN MATTERS FEBRUARY 7TH 2014

Regulatory Science: FDA Paths Forward With Real World Evidence Mitchell W. Krucoff, MD, FACC

Development of a patient-specific modular vascular phantom with clinically relevant mechanical properties. Academic Year:

A Path from RWD to RWE Stopping Over at Statistical Inference

Prediction of altered endograft path during endovascular abdominal aortic aneurysm repair with the Gore Excluder

Statement of the. Society for Cardiovascular Angiography & Interventions. Presented by. Augusto D. Pichard, MD, FSCAI. Before the

Clinical evaluation of the swirling flow stent: the MIMICS experience

Hybrid Rooms for Interventional Radiology

Medtronic Life Sciences Case Study

Issues in Clinical Trial Designs for Devices

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2

Simulator Features. Sanford-USD Surgical Residency and Cardiac Fellowship programs IMAGING. C-arm and patient table maneuvering

Simulator Features. Sanford-USD Surgical Residency and Cardiac Fellowship programs IMAGING. C-arm and patient table maneuvering

Outline. Outline. State of the Art: New Technologies in Endoscopy. The era of lumen-apposing metallic stents (LAMS)

European Journal of Vascular and Endovascular Surgery

Aortic Graft Infection- Contemporary Management of a Resurgent Problem

Piloting the National Cardiovascular Research Infrastructure: The SAFE-PCI for Women Trial

The Endoscope is a Surgical Tool When in the Hands of Surgeons.

Field trial with veterinary vaccine

Dose Reduction during EVAR in Hybrid Room. Multicentric Study

Development of a Finite Element Model to Analyse the Proximal Ring of an Endovascular Device

Resolute in the DES era: Indications & Limitations

Bioabsorbable Stents. The Ideal Scaffold properties and kinetics. Jonathan Hill King s College Hospital King s Health Partners

Registry Assessment of Peripheral Interventional Devices (RAPID)

The technologies described in this document are in development and are not available for clinical use

Found: 30% of 25% eligible predicted by chart review; randomized: 28% of goal! Page 1

Prestige Pilot: Phoenix atherectomy and Stellarex DCB in BTK interventions. Michael K. W. Lichtenberg MD, FESC

Current hospital costs and Medicare reimbursement for endovascular abdominal aortic aneurysm repair

Transcription:

V. Riambau, MD, PhD Professor and Chief of Vascular Surgery Division CardioVascular Institute, Hospital Clinic, University of Barcelona vriambau@clinic.ub.es

Consultant/Advisor Bolton Medical Cordis Bard Medtronic Aptus Lombard Medical ivascular MSD Bayer Astra Zeneca Proctor Bolton Medical Cook Medtronic W.L. Gore Aptus Cordis

Background Product Overview Clinical insights and results Case Examples & technical tips Summary

Background Product Overview Clinical insights and results Case Examples & technical tips Summary

EVAR reintervention rates worsen over time EVAR 1 DREAM OVER R.M. Greenhalgh et al. N Engl J Med 2010 De Bruin et al. N Engl J Med 2010 FA Lederle et al N Engl J Med 2012 Stather et al B J Surg, 2013

Predictor neck anatomic factors for EVAR failure Evaluated N=221 patients from ANCHOR post-market registry Failure defined as: Type Ia endoleak upon endograft implantation Type Ia endoleak identified in post-op follow-up* Identified proximal neck variables that independently predict type Ia endoleak: Neck diameter Neck length 26 mm P =.002 17 mm P =.017 *In endografts without EndoAnchors Certain on-label necks can be at-risk Jordan WD et al. J Vasc Surg. 2015

Neck dilation in EVAR remains REAL Mid-long term Any self expandable graft Up 2/3 of the cases after 7 y f-u Increases the migration rate up to 5 times Author Follow- Up Grafts studied Proximal Neck Dilatation Rate Outcomes in dilated necks Oberhuber et al. 1 39 mos average Zenith (N=29), Talent (N=35), Excluder (N=39) 22% (defined as >2mm diam increase) 31% reinterventions Pintoux et al. 2 57 mos average Talent (N=33), AneuRx (N=25) 24% (defined as >3mm diam increase) 5% late type Ia endoleak 16% migration Bastos Gonçalves et al. 3 5 yrs median Excluder (N=144) 37% overall, 66% in pts >7 yrs f/u (defined as >2mm diam increase) Increased odds of migration ( 5mm) 5.5x 1 Oberhuber A et al. J Vasc Surg 2012 April;55(4): 929-34 2 Pintoux D et al. Ann Vasc Surg. 2011 Nov;25(8):1012-9 3 Bastos Goncalves F et al. J Vasc Surg. 2012 Oct;56(4):920-8

CURRENT OPTIONS: Open Surgical Repair (OSR) FEVAR Off-the-shelf branch ChEVAR (parallel graft) Aneurysm filling LIMITATIONS: OSR FEVAR BRANCH ChEVAR Aneurysm Filling Patients not eligible due to significant co-morbidities Long recovery ICU Expensive Complex Custom-made not available for raaa Limited in angled anatomies Steep learning curve Long term reinterventions Experimental Steep learning curve Patient applicability not as high as originally perceived Lack of robust clinical evidence Lack of robust clinical evidence to prove safety and efficacy Technique not standardized Current technology lacks robust clinical evidence to prove safety and efficacy Changes to blood-flow dynamics

Complementary Technologies with existing stent graft technology APTUS Endo Anchoring System (Heli-FX ) An off-the-shelf Solution

Displacement force in Newtons CREATE THE STABILITY OF A SURGICAL ANASTOMOSIS IN EVAR AND TEVAR Surgical Anastomosis EndoAnchoring 150 100 50 0 Talent Endurant Excluder Zenith Mean Hand Sewn No EndoAnchors With EndoAnchors Chart from data published in Melas N, et al. J Vasc Surg 2012;55(6):1726-33 Case images courtesy of John Aruny MD, Bart Edward Muhs, MD, PhD. 10

Fixation tested to 500mm/Hg without failure

Background Product Overview Clinical insights and results Case Examples & technical tips Summary

3 mm Cross Bar 1.0 mm 3.5 mm 14

Hostile Anatomy Overcoming concerns for implant stability PROPHYLAXIS Normal Anatomy Mitigating risk of reinterventions TREATMENT Resolve proximal seal failures Challenging neck anatomies (e.g. wide, short, conical, angulated) Difficult landing Severe comorbidities that preclude safe reintervention Patients potentially lost during F/U Targeted sealing of acute type I endoleaks Targeted sealing of late type I endoleaks (e.g. birdbeaking, close to branched vessels) Long remaining life expectancy (young pts) Augmented stability in migrated grafts Case image from Gandhi RT, Katzen BT Treating a Type 1A Endoleak Using EndoAnchors. Endovascular Today March 2012 23:26. 15

16

Aptus Heli-FX Thoracic EndoAnchor System 18Fr OD, 90cm working length Aptus Heli-FX EndoAnchor System 16Fr OD, 62cm working length 17

The Aptus EndoAnchor and Heli-FX have been evaluated and determined to be compatible with the following endografts: Medtronic Talent Medtronic AneuRx Medtronic Endurant Cook Zenith Gore Excluder Jotec GmbH 18

AP 45 RAO 45 LAO Note: C-arm positions above show just one possible combination 19

AP 60 RAO 60 LAO Note: C-arm positions above show just one possible combination 20

Move C-Arm in 15-20 degree increments Identify leak channel and then create a suture line along wall. Circumferential anchoring before/after T1 EL treatment is recommended: address concerns of long-term neck morphology changes 21

Background Product Overview Clinical insights and results Case Examples & technical tips Summary

Registry Principal Investigators Registry Design Treatment Arms Enrollment & Duration Follow-up Europe: Dr Jean-Paul de Vries Chief of Vascular Surgery, St. Antonius Hospital US: Dr William Jordan Chief of Vascular Surgery/Endovascular Therapy, Emory University School of Medicine Prospective, observational, international, multicenter, dual-arm Registry Primary Up to 1000 pts, Prophylactic Revision Up to 1000 pts, Therapeutic Enrollment began 2012 and patients will be followed for 5 years Per Standard of Care at each center & discretion of Investigator Over 600 Patients enrolled as of November 2015

PROXIMAL ENDOLEAKS AND MIGRATION MEAN FOLLOW-UP 8.2 MONTHS All Primary Cases Type Ia Endoleaks 1a ELs CTs % 3 177 1.7% Endograft Migration (>10mm) All Primary Cases Migration CTs % 0 112 0.0% Migration was assessed in comparison to the 1-month CT scan

Persistent/Recurrent type Ia endoleaks CORE LAB MEAN CT FOLLOW-UP 10.4 MONTHS Cohort All Cases 1a ELs CTs % All 24 142 16.9% Primary 3 76 3.9% Revision 21 66 31.8%

Background Product Overview Clinical insights and results Case Examples & technical tips Summary

2 EndoAnchor Case Book June 1, 2015 Post balloon Type 1

2

2 EndoAnchor Case Book June 1, 2015

3 EndoAnchor Case Book June 1, 2015 Late type I endoleak Cuff and EndoAnchors implanted Endoleak resolved

3 EndoAnchor Case Book June 1, 2015

3 EndoAnchor Case Book June 1, 2015 Late endograft migration with Type Ia endoleak Cuff and EndoAnchors implanted Endoleak resolved

63y/o Female Short proximal neck/seal zone LSA transposition performed prior to primary TEVAR Case images courtesy of Thomas Naslund, MD Vanderbilt University Medical Center

Final angio: No endoleak Enhanced fixation in short seal zone Case images courtesy of Thomas Naslund, MD Vanderbilt University Medical Center

Distal neck =3cm, 63 yo lady 3cm 2011 2013 2016

Background Product Overview Clinical insights and results Case Examples & technical tips Summary

Hostile necks compromise early and long term outcomes for EVAR EndoAnchors are designed to bring long-term stability of surgical anastomosis to EVAR/TEVAR ANCHOR registry demonstrates >90% success rate, no migration and <2% type 1a EL when Endoanchors are prophylactically applied in hostile necks (especially in young patients) Endoanchors as a therapeutical tool, shows a >80% of success rate, but about 17% of type I ELs remain permanent NO endoanchors-related adverse events have been reported in my knowledge.

V. Riambau, MD, PhD Professor and Chief of Vascular Surgery Division CardioVascular Institute, Hospital Clinic, University of Barcelona vriambau@clinic.ub.es